Lung Cancer Risk Attributable to Active Smoking in China: A Systematic Review and Meta-Analysis

No consensus exists on the relative risk (RR) of lung cancer (LC) attributable to active smoking in China. This study aimed to evaluate the unified RR of LC attributable to active smoking among the Chinese population. A systematic literature search of seven databases was conducted to identify studie...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomedical and environmental sciences 2023-09, Vol.36 (9), p.850-861
Hauptverfasser: ZHAO, Jian, SHI, Yu Lin, WANG, Yu Tong, AI, Fei Ling, WANG, Xue Wei, YANG, Wen Yi, WANG, Jing Xin, AI, Li Mei, HU, Kui Ru, WAN, Xia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:No consensus exists on the relative risk (RR) of lung cancer (LC) attributable to active smoking in China. This study aimed to evaluate the unified RR of LC attributable to active smoking among the Chinese population. A systematic literature search of seven databases was conducted to identify studies reporting active smoking among smokers versus nonsmokers in China. Primary articles on LC providing risk estimates with their 95% confidence intervals (CIs) for “ever” “former” or “current” smokers from China were selected. Meta-analysis was used to estimate the pooled RR of active smoking. Forty-four unique studies were included. Compared with that of nonsmokers, the pooled RR (95% CI) for “ever” “former” and “current” smokers were 3.26 (2.79–3.82), 2.95 (1.71–5.08), and 5.16 (2.58–10.34) among men, 3.18 (2.78–3.63), 2.70 (2.08–3.51), and 4.27 (3.61–5.06) among women, and 2.71 (2.12–3.46), 2.66 (2.45–2.88), and 4.21 (3.25–5.45) in both sexes combined, respectively. The RR of LC has remained relatively stable (range, 2–6) over the past four decades in China. Early quitting of smoking could reduce the RR to some extent; however, completely refraining from smoking is the best way to avoid its adverse effects.
ISSN:0895-3988
2214-0190
DOI:10.3967/bes2023.075